MMP-2 can induce the release of transforming growth factor-beta (TGFβ) and the cleavage of interleukin-1β, which are both related to tumor progression in lung cancer (Sounni et al., 2011; Hannocks et al., 2019). This evidence concerns the gene TGFB1 and lung cancer.